Chinopoulos Christos: Difference between revisions
No edit summary |
No edit summary |
||
(28 intermediate revisions by 8 users not shown) | |||
Line 1: | Line 1: | ||
{{EAGLE | {{EAGLE | ||
|COST= | |COST= Member | ||
|COST WG1 = WG1 | |||
|COST Mentor= Mentor | |||
}} | }} | ||
: [[Management_Committee_MitoEAGLE#MC_Members|MC Member]] - [[Management Committee MitoEAGLE]] | |||
{{Person | {{Person | ||
|lastname=Chinopoulos | |lastname=Chinopoulos | ||
Line 8: | Line 11: | ||
|institution=[[File:Christos Chinopoulos.jpg|right|150px|Christos Chinopoulos]] | |institution=[[File:Christos Chinopoulos.jpg|right|150px|Christos Chinopoulos]] | ||
Department of Medical Biochemistry | Department of Medical Biochemistry, | ||
Semmelweis University | Semmelweis University, HU | ||
|address=Tuzolto st. 37-47 | |address=Tuzolto st. 37-47 | ||
|area code=1094 | |area code=1094 | ||
|city=Budapest | |city=Budapest | ||
|country=Hungary | |country=Hungary | ||
|mailaddress=chinopoulos.christos@ | |||
|weblink=[http://www.oxphos.org/index.php?option=content&task=view&id=55 Christos Chinopoulos] | |weblink=[http://www.oxphos.org/index.php?option=content&task=view&id=55 Christos Chinopoulos] | ||
}} | }} | ||
__TOC__ | |||
== Bioenergetics Communications == | |||
::::* Christos Chinopoulos is an Executive Editor of the journal '''[[Bioenergetics Communications]]''' | |||
:::::'''Keywords:''' mitochondria, oncometabolism, tumor metabolism, substrate-level phosphorylation | |||
{{NextGen-O2k H2020-support}} | |||
== NextGen-O2k == | |||
::::* Prof. Christos Chinopoulos is Key Opinion Leader (KOL) in the [[NextGen-O2k]] project. | |||
== MitoEAGLE Short-Term Scientific Mission == | |||
****: [[Short-Term Scientific Missions MitoEAGLE#STSM_Grant_Period_2 |STSM Grant Period 2]] | |||
::: '''Work Plan summary''' | |||
:::: In our laboratory we examine the contribution of mitochondrial substrate-level phosphorylation (mSLP) to ATP output and ANT directionality during true anoxia or inhibition of the electron transport chain (ETC) in isolated mitochondria or permeabilized cells. True anoxia is ensured by monitoring oxygen concentration in sealed Oroboros chambers when mitochondria respire on various substrates in the abundance of ADP. On the other hand, chemical anoxia is induced by targeted inhibition of ETC components. Under such conditions mSLP is addressed by protocols relying on membrane potential measurements using safranine O, also monitored by the O2k-Fluo LED2-Module, as described elsewhere (FASEB J. 2010, 24:2405). However, it has come to our attention that targeted inhibition of complex I perturbs mSLP even in the presence of true anoxia. Parallel to these measurements, metabolomic analysis of citricacid cycle metabolites obtained from fractions of such experiments hint on a privileged dependence of complex I activity to KGDHC. Currently, we are attempting to address this further by measuring NADH in standard fluorimetric cuvettes using home-made 3D-printed plugs in order to induce and maintain anoxia where we can also measure membrane potential by safranine O among other parameters. However, we are only partially successful, and we need to be able to measure oxygen, NADH and safranine O fluorescence in the same samples (albeit in different chambers), simultaneously. The O2k-NextGen is designed by Oroboros for achieving exactly that. The plan is to isolate mouse liver mitochondria, subject them to ADP and substrates in sealed Oroboros chambers, attain anoxia, add the ETC inhibitors and collect fractions at various time points to be evaluated by untargeted metabolomic analysis. Anoxia, NADH levels and membrane potential will be measured throughout these experiments and complement the results of the metabolomic analysis. | |||
== Participated at == | |||
::::* [[MiPNet 26.16 NextGen-O2k Summit 2021 Virtual|NextGen-O2k Summit 2021 Virtual]] | |||
::::* [[IOC141|IOC141 Schroecken AT]] | |||
::::* [[MitoEAGLE_Innsbruck_2018-11-19| MitoEAGLE 2018 Innsbruck AT]] | |||
::::* [[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 Jurmala LV]] | |||
::::* [[IOC127|IOC127 Szeged HU]] | |||
::::* [[MitoFit Workshop ATP 2017 Innsbruck AT]] | |||
::::* [[IOC116|IOC116 Innsbruck AT]] | |||
::::* [[Bioblast 2012 | Bioblast 2012 Innsbruck AT]] | |||
::::* [[IOC66 | IOC66 Innsbruck AT]] | |||
::::* [[IOC127|IOC127 Szeged HU]] | |||
== Visiting scientist in the Oroboros O2k-Laboratory == | |||
:::: [[Image:O2k-Network.png|left|40px|link=O2k-Network|O2k-Network]] | |||
[[Chinopoulos Christos| Christos Chinopoulos ]]: Visiting scientist at the [[Oroboros Laboratories: visiting scientists |Oroboros O2k-Laboratory]] | |||
::::::* December 14 to December 22 2017 | |||
{{Labelingperson | {{Labelingperson | ||
|field of research=Basic | |field of research=Basic | ||
|topics=Mitochondrial mechanisms of neurodegeneration, Permeability transition pore | |topics=Mitochondrial mechanisms of neurodegeneration, Permeability transition pore | ||
}} | }} | ||
Latest revision as of 11:16, 3 May 2024
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Chinopoulos Christos
MitoPedia topics: MitoPedia topic::EAGLE
COST: Has COST::Member COST WG1: Has COST WG1::WG1
COST Mentor: Has COST Mentor::Mentor
Name | Has lastname::Chinopoulos Has firstname::Christos, Has title::MD, PhD, Associate Professor |
---|---|
Institution | [[Has institution::
Department of Medical Biochemistry, Semmelweis University, HU]] |
Address | Has address::Tuzolto st. 37-47, Has area code::1094 |
City | In city::Budapest |
State/Province | In state:: |
Country | In country::Hungary |
Has mailaddress::[email protected] | |
Weblink | [[Weblink::Christos Chinopoulos]] |
O2k-Network Lab | {{#ask:has member::Chinopoulos Christos}} |
Bioenergetics Communications
- Christos Chinopoulos is an Executive Editor of the journal Bioenergetics Communications
- Keywords: mitochondria, oncometabolism, tumor metabolism, substrate-level phosphorylation
NextGen-O2k
- Prof. Christos Chinopoulos is Key Opinion Leader (KOL) in the NextGen-O2k project.
MitoEAGLE Short-Term Scientific Mission
- Work Plan summary
- In our laboratory we examine the contribution of mitochondrial substrate-level phosphorylation (mSLP) to ATP output and ANT directionality during true anoxia or inhibition of the electron transport chain (ETC) in isolated mitochondria or permeabilized cells. True anoxia is ensured by monitoring oxygen concentration in sealed Oroboros chambers when mitochondria respire on various substrates in the abundance of ADP. On the other hand, chemical anoxia is induced by targeted inhibition of ETC components. Under such conditions mSLP is addressed by protocols relying on membrane potential measurements using safranine O, also monitored by the O2k-Fluo LED2-Module, as described elsewhere (FASEB J. 2010, 24:2405). However, it has come to our attention that targeted inhibition of complex I perturbs mSLP even in the presence of true anoxia. Parallel to these measurements, metabolomic analysis of citricacid cycle metabolites obtained from fractions of such experiments hint on a privileged dependence of complex I activity to KGDHC. Currently, we are attempting to address this further by measuring NADH in standard fluorimetric cuvettes using home-made 3D-printed plugs in order to induce and maintain anoxia where we can also measure membrane potential by safranine O among other parameters. However, we are only partially successful, and we need to be able to measure oxygen, NADH and safranine O fluorescence in the same samples (albeit in different chambers), simultaneously. The O2k-NextGen is designed by Oroboros for achieving exactly that. The plan is to isolate mouse liver mitochondria, subject them to ADP and substrates in sealed Oroboros chambers, attain anoxia, add the ETC inhibitors and collect fractions at various time points to be evaluated by untargeted metabolomic analysis. Anoxia, NADH levels and membrane potential will be measured throughout these experiments and complement the results of the metabolomic analysis.
- Work Plan summary
Participated at
Visiting scientist in the Oroboros O2k-Laboratory
Christos Chinopoulos : Visiting scientist at the Oroboros O2k-Laboratory
- December 14 to December 22 2017
Labels:
Field of research: field of research::Basic
Topics: topics::Mitochondrial mechanisms of neurodegeneration, topics::Permeability transition pore
Publications
{{#ask:was written by::Chinopoulos Christos|format=table|sort=was published in year|order=desc|default=Add references to your publications
| ?was published in year=Published
| ?has title=Reference
| limit=2000
}}
Abstracts
{{#ask:was written by::Chinopoulos Christos|format=table|sort=was submitted in year|order=desc|default=Add abstract
| ?was submitted in year=Published
| ?has title=Reference
| limit=2000
}}